These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 25554349)

  • 1. Polysomnographic and actigraphic characteristics of patients with H1N1-vaccine-related and sporadic narcolepsy.
    Alakuijala A; Sarkanen T; Partinen M
    Sleep Med; 2015 Jan; 16(1):39-44. PubMed ID: 25554349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France.
    Dauvilliers Y; Arnulf I; Lecendreux M; Monaca Charley C; Franco P; Drouot X; d'Ortho MP; Launois S; Lignot S; Bourgin P; Nogues B; Rey M; Bayard S; Scholz S; Lavault S; Tubert-Bitter P; Saussier C; Pariente A;
    Brain; 2013 Aug; 136(Pt 8):2486-96. PubMed ID: 23884811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A.
    Heier MS; Gautvik KM; Wannag E; Bronder KH; Midtlyng E; Kamaleri Y; Storsaeter J
    Sleep Med; 2013 Sep; 14(9):867-71. PubMed ID: 23773727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Childhood narcolepsy with cataplexy: comparison between post-H1N1 vaccination and sporadic cases.
    Pizza F; Peltola H; Sarkanen T; Moghadam KK; Plazzi G; Partinen M
    Sleep Med; 2014 Feb; 15(2):262-5. PubMed ID: 24468101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis.
    Miller E; Andrews N; Stellitano L; Stowe J; Winstone AM; Shneerson J; Verity C
    BMJ; 2013 Feb; 346():f794. PubMed ID: 23444425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010.
    Lind A; Ramelius A; Olsson T; Arnheim-Dahlström L; Lamb F; Khademi M; Ambati A; Maeurer M; Nilsson AL; Bomfim IL; Fink K; Lernmark Å
    J Autoimmun; 2014 May; 50():99-106. PubMed ID: 24485154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy risk.
    Vaarala O; Vuorela A; Partinen M; Baumann M; Freitag TL; Meri S; Saavalainen P; Jauhiainen M; Soliymani R; Kirjavainen T; Olsen P; Saarenpää-Heikkilä O; Rouvinen J; Roivainen M; Nohynek H; Jokinen J; Julkunen I; Kilpi T
    PLoS One; 2014; 9(12):e114361. PubMed ID: 25501681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single center analysis of patients with H1N1 vaccine-related narcolepsy and sporadic narcolepsy presenting over the same time period.
    Ferguson D; Wrigley S; Purcell E; Keane S; McGinn B; O'Malley S; Lynch B; Crowe C
    J Clin Sleep Med; 2021 May; 17(5):885-895. PubMed ID: 33289477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in risk for narcolepsy over time and impact of definition of onset date following vaccination with AS03 adjuvanted pandemic A/H1N1 influenza vaccine (Pandemrix) during the 2009 H1N1 influenza pandemic.
    Granath F; Gedeborg R; Smedje H; Feltelius N
    Pharmacoepidemiol Drug Saf; 2019 Aug; 28(8):1045-1053. PubMed ID: 31062443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Narcolepsy after AS03 Adjuvanted Pandemic A/H1N1 2009 Influenza Vaccine in Adults: A Case-Coverage Study in England.
    Stowe J; Andrews N; Kosky C; Dennis G; Eriksson S; Hall A; Leschziner G; Reading P; Shneerson JM; Donegan K; Miller E
    Sleep; 2016 May; 39(5):1051-7. PubMed ID: 26856903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus.
    Saariaho AH; Vuorela A; Freitag TL; Pizza F; Plazzi G; Partinen M; Vaarala O; Meri S
    J Autoimmun; 2015 Sep; 63():68-75. PubMed ID: 26227560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased muscle activity during sleep and more RBD symptoms in H1N1-(Pandemrix)-vaccinated narcolepsy type 1 patients compared with their non-narcoleptic siblings.
    Viste R; Follin LF; Kornum BR; Lie BA; Viken MK; Thorsby PM; Rootwelt T; Christensen JAE; Knudsen-Heier S
    Sleep; 2023 Mar; 46(3):. PubMed ID: 36562330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Narcolepsy Associated with Pandemrix Vaccine.
    Sarkanen T; Alakuijala A; Julkunen I; Partinen M
    Curr Neurol Neurosci Rep; 2018 Jun; 18(7):43. PubMed ID: 29855798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland.
    Melén K; Partinen M; Tynell J; Sillanpää M; Himanen SL; Saarenpää-Heikkilä O; Hublin C; Olsen P; Ilonen J; Nohynek H; Syrjänen R; Kilpi T; Vuorela A; Kirjavainen T; Vaarala O; Julkunen I
    PLoS One; 2013; 8(8):e68402. PubMed ID: 23950869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence rates of narcolepsy diagnoses in Taiwan, Canada, and Europe: The use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues on a population level in the SOMNIA study.
    Dodd CN; de Ridder M; Huang WT; Weibel D; Giner-Soriano M; Perez-Vilar S; Diez-Domingo J; Svenson LW; Mahmud SM; Carleton B; Naus M; Kwong JC; Murray BJ; Arnheim-Dahlstrom L; Pedersen L; Morros R; Puertas FJ; Black S; Sturkenboom M
    PLoS One; 2018; 13(10):e0204799. PubMed ID: 30332477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome.
    Marti I; Valko PO; Khatami R; Bassetti CL; Baumann CR
    Sleep Med; 2009 Dec; 10(10):1146-50. PubMed ID: 19464232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-random temporal distribution of sleep onset REM periods in the MSLT in narcolepsy.
    Sansa G; Falup-Pecurariu C; Salamero M; Iranzo A; Santamaria J
    J Neurol Sci; 2014 Jun; 341(1-2):136-8. PubMed ID: 24735736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actigraphic assessment of sleep/wake behavior in central disorders of hypersomnolence.
    Filardi M; Pizza F; Martoni M; Vandi S; Plazzi G; Natale V
    Sleep Med; 2015 Jan; 16(1):126-30. PubMed ID: 25547035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reassessment of the risk of narcolepsy in children in England 8 years after receipt of the AS03-adjuvanted H1N1 pandemic vaccine: A case-coverage study.
    Stowe J; Andrews N; Gringras P; Quinnell T; Zaiwalla Z; Shneerson J; Miller E
    PLoS Med; 2020 Sep; 17(9):e1003225. PubMed ID: 32926731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns.
    Wijnans L; Lecomte C; de Vries C; Weibel D; Sammon C; Hviid A; Svanström H; Mølgaard-Nielsen D; Heijbel H; Dahlström LA; Hallgren J; Sparen P; Jennum P; Mosseveld M; Schuemie M; van der Maas N; Partinen M; Romio S; Trotta F; Santuccio C; Menna A; Plazzi G; Moghadam KK; Ferro S; Lammers GJ; Overeem S; Johansen K; Kramarz P; Bonhoeffer J; Sturkenboom MC
    Vaccine; 2013 Feb; 31(8):1246-54. PubMed ID: 23246544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.